Mkam Etf (NASDAQ:MKAM – Get Free Report) saw a significant decrease in short interest in the month of October. As of October 15th, there was short interest totaling 442 shares, a decrease of 42.7% from the September 30th total of 771 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 226 shares, the short-interest ratio is presently 2.0 days.
Mkam Etf Trading Down 0.6%
Shares of Mkam Etf stock traded down $0.20 on Friday, hitting $32.16. The stock had a trading volume of 7 shares, compared to its average volume of 596. The company’s 50 day moving average price is $32.33 and its 200 day moving average price is $31.57. Mkam Etf has a 52-week low of $29.78 and a 52-week high of $32.56. The stock has a market cap of $13.51 million, a price-to-earnings ratio of 24.59 and a beta of 0.41.
Mkam Etf Cuts Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Monday, September 28th were issued a dividend of $0.1471 per share. The ex-dividend date was Monday, September 28th. This represents a $0.59 annualized dividend and a yield of 1.8%. This is a drop from Mkam Etf’s previous quarterly dividend of $0.1531.
About Mkam Etf
The MKAM ETF (MKAM) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund seeks to provide the performance return of US large-cap equities, but with less volatility and downside risk. The actively managed fund utilizes a proprietary multi-factor model to shift the portfolios exposure between equities and fixed income investments. MKAM was launched on Apr 12, 2023 and is managed by MKAM.
Further Reading
- Five stocks we like better than Mkam Etf
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Mkam Etf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mkam Etf and related companies with MarketBeat.com's FREE daily email newsletter.
